drugset / Trial / NCT03686059

Outcome of Omega 3 FA and Punctal Plugs on Ocular Surface Disease

NCT03686059

Phase 4 Completed 90 enrolled Benha University
RandomizedParallel-groupSingle-blindTreatment

Summary

Ocular surface disease is a common adverse effect of systemic isotretinoin therapy. The investigators consider that punctal plugs and Omega 3 is a good line for treatment of ocular surface disease associated with systemic isotretinoin therapy

Timeline

Start
2018-07-02
Primary completion
2019-11-15
Completion
2019-11-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Omega-3 fatty acids Unknown 250 mg

Indications